This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Basu, A Articles by Das, M Search for Related Content PubMed PubMed Citation Articles by Basu, A Articles by Das, M

 Previous Article  |  Next Article 

Mol Cell Biol. 1989 February; 9(2): 671-677

Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor interaction in kinase regulation.

Department of Biochemistry and Biophysics, Children's Hospital of Philadelphia, Pennsylvania.

ABSTRACT

The tyrosine kinase activity of the epidermal growth factor (EGF) receptor is regulated by a truncated receptor of 100 kilodaltons (kDa) that contains the EGF-binding site but not the kinase domain. The inhibition of kinase is not due to competition for available EGF or for the kinase substrate-binding site. Chemical cross-linking studies suggest that the 100-kDa receptor may form a heterodimer with the intact EGF receptor. Structurally related receptor kinases, such as the platelet-derived growth factor receptor, the insulin receptor, and the Neu receptor, were not inhibited by the 100-kDa receptor. The results indicate that (i) the inhibition was specific for the EGF receptor, (ii) the kinase domain had little or no role in determining target specificity, and (iii) the regulation of kinase may be due to a specific interaction of the 100-kDa receptor with the ligand-binding domain of the EGF receptor kinase.

This article has been cited by other articles:

• Bertenshaw, G. P., Yip, P., Seshaiah, P., Zhao, J., Chen, T.-H., Wiggins, W. S., Mapes, J. P., Mansfield, B. C. (2008). Multianalyte Profiling of Serum Antigens and Autoimmune and Infectious Disease Molecules to Identify Biomarkers Dysregulated in Epithelial Ovarian Cancer. Cancer Epidemiol. Biomarkers Prev. 17: 2872-2881 [Abstract] [Full Text]  
• Reiter, J. L., Maihle, N. J., Clinton, G. M. (2006). Therapeutic potential of epidermal growth factor receptor-related protein.. Molecular Cancer Therapeutics 5: 2954-2954 [Full Text]  
• Chan, J. K., Pham, H., You, X. J., Cloven, N. G., Burger, R. A., Rose, G. S., Van Nostrand, K., Korc, M., DiSaia, P. J., Fan, H. (2005). Suppression of Ovarian Cancer Cell Tumorigenicity and Evasion of Cisplatin Resistance Using a Truncated Epidermal Growth Factor Receptor in a Rat Model. Cancer Res. 65: 3243-3248 [Abstract] [Full Text]  
• Moon, W S, Tarnawski, A S, Chai, J, Yang, J T, Majumdar, A P N (2005). Reduced expression of epidermal growth factor receptor related protein in gastric cancer. Gut 54: 201-206 [Abstract] [Full Text]  
• Coers, J., Ranft, C., Skoda, R. C. (2004). A Truncated Isoform of c-Mpl with an Essential C-terminal Peptide Targets the Full-length Receptor for Degradation. J. Biol. Chem. 279: 36397-36404 [Abstract] [Full Text]  
• Lee, H., Akita, R. W., Sliwkowski, M. X., Maihle, N. J. (2001). A Naturally Occurring Secreted Human ErbB3 Receptor Isoform Inhibits Heregulin-stimulated Activation of ErbB2, ErbB3, and ErbB4. Cancer Res. 61: 4467-4473 [Abstract] [Full Text]  
• Shintani, S., Matsuo, K., Crohin, C. C., McBride, J., Tsuji, T., Donoff, R. B., Posner, M., Todd, R., Wong, D. T.W. (1999). Intragenic Mutation Analysis of the Human Epidermal Growth Factor Receptor (EGFR) Gene in Malignant Human Oral Keratinocytes. Cancer Res. 59: 4142-4147 [Abstract] [Full Text]  
• Maeda, T., Yamada, Y., Moriuchi, R., Sugahara, K., Tsuruda, K., Joh, T., Atogami, S., Tsukasaki, K., Tomonaga, M., Kamihira, S. (1999). Fas Gene Mutation in the Progression of Adult T Cell Leukemia. J. Exp. Med. 189: 1063-1071 [Abstract] [Full Text]  
• Trusolino, L., Pugliese, L., Comoglio, P. M. (1998). Interactions between scatter factors and their receptors: hints for therapeutic applications. FASEB J. 12: 1267-1280 [Abstract] [Full Text]  
• Yabkowitz, R., Meyer, S., Yanagihara, D., Brankow, D., Staley, T., Elliott, G., Hu, S., Ratzkin, B. (1997). Regulation of Tie Receptor Expression on Human Endothelial Cells by Protein Kinase C-Mediated Release of Soluble Tie. Blood 90: 706-715 [Abstract] [Full Text]  
• McBean, J. H., Brumsted, J. R., Stirewalt, W. S. (1997). In Vivo Estrogen Regulation of Epidermal Growth Factor Receptor in Human Endometrium. J. Clin. Endocrinol. Metab. 82: 1467-1471 [Abstract] [Full Text]  
• Chantry, A., Chantry, A. (1995). The Kinase Domain and Membrane Localization Determine Intracellular Interactions between Epidermal Growth Factor Receptors. J. Biol. Chem. 270: 3068-3073 [Abstract] [Full Text]  
• O'Bryan, J. P., Fridell, Y.-W., Koski, R., Varnum, B., Liu, E. T. (1995). The Transforming Receptor Tyrosine Kinase, Axl, Is Post-translationally Regulated by Proteolytic Cleavage. J. Biol. Chem. 270: 551-557 [Abstract] [Full Text]  
• Schneider, D S, Hudson, K L, Lin, T Y, Anderson, K V (1991). Dominant and recessive mutations define functional domains of Toll, a transmembrane protein required for dorsal-ventral polarity in the Drosophila embryo.. Genes Dev. 5: 797-807 [Abstract]  
• Reith, A D, Rottapel, R, Giddens, E, Brady, C, Forrester, L, Bernstein, A (1990). W mutant mice with mild or severe developmental defects contain distinct point mutations in the kinase domain of the c-kit receptor.. Genes Dev. 4: 390-400 [Abstract]